Literature DB >> 4629112

A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients.

B Shopsin, E Pearson, S Gershon, P Collins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4629112

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN: 0011-393X


× No keyword cloud information.
  6 in total

Review 1.  Antipsychotic drugs: clinical pharmacology and therapeutic use.

Authors:  J M Davis; R Casper
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546

Review 2.  Loxapine: a review of its pharmacological properties and therapeutic efficacy as an antipsychotic agent.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-03       Impact factor: 9.546

3.  What's new in the psychopharmacology of schizophrenia.

Authors:  A Rifkin; F Quitkin
Journal:  Bull N Y Acad Med       Date:  1978-10

4.  Quality of reports of clinical trials submitted by the drug industry to the Finnish and Swedish control authorities.

Authors:  E Hemminki
Journal:  Eur J Clin Pharmacol       Date:  1981-02       Impact factor: 2.953

Review 5.  Loxapine for schizophrenia.

Authors:  A Chakrabarti; A Bagnall; P Chue; M Fenton; V Palaniswamy; W Wong; J Xia
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

6.  Revisiting loxapine: a systematic review.

Authors:  Dina Popovic; Philippe Nuss; Eduard Vieta
Journal:  Ann Gen Psychiatry       Date:  2015-04-01       Impact factor: 3.455

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.